Ajanta Pharma Limited (AJANTPHARM) Share Analysis
NSE · Healthcare · Pharmaceuticals
Ajanta Pharma Limited (NSE: AJANTPHARM) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400. As of 21 Sep 2026, the share price was ₹3,564.00, market capitalisation ₹44,530 Cr, P/E 39.2, ROE 27.1%.
Get the AI verdict on AJANTPHARM: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
AJANTPHARM price and valuation
- Share price
- ₹3,564.00
- Market cap
- ₹44,530 Cr
- P/E ratio
- 39.2
- P/B ratio
- 9.85
- EPS
- ₹90.84
- Book value per share
- ₹362.00
- Dividend yield
- 0.9%
AJANTPHARM profitability and growth
- ROE
- 27.1%
- ROCE
- 34.5%
- Debt to equity
- 0.06
- Revenue growth (3 yr)
- 13%
- Revenue growth (5 yr)
- 14%
- Profit growth (3 yr)
- 24%
- Profit growth (5 yr)
- 12%
AJANTPHARM 52-week range
- 52-week high
- ₹3,796.00
- 52-week low
- ₹2,329.90
- Face value
- ₹2.00
AJANTPHARM shareholding pattern
- Promoters
- 63.49%
- FIIs
- 7.68%
- DIIs
- 21.8%
- Public
- 7.03%
Index membership: NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400, NIFTY Pharma.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.